McKesson | 8-K: Closing of Notes Offering
McKesson | 8-K: Mckesson Corporation to Participate in the Wells Fargo 2024 Healthcare Conference on September 5, 2024
McKesson | 8-K: McKesson Signs Agreement to Acquire Controlling Interest in Florida Cancer Specialists & Research Institute's Core Ventures
McKesson | 8-K: McKESSON CORPORATION REPORTS FISCAL 2025 FIRST QUARTER RESULTS
McKesson | 8-K: Poll Results of 2024 Stockholders Meeting
McKesson | DEFA14A: Others
McKesson | DEF 14A: Definitive information statements
McKesson | DEFA14A: Others
McKesson | PRE 14A: Preliminary proxy statements relating to merger or acquisition
McKesson | 8-K: McKesson's Board of Directors Elects Deborah Dunsire as New Director
McKesson | 8-K: McKESSON CORPORATION REPORTS FISCAL 2024 FOURTH QUARTER AND FULL YEAR RESULTS
McKesson | 8-K: McKESSON CORPORATION REPORTS FISCAL 2024 THIRD QUARTER RESULTS AND RAISES FULL YEAR GUIDANCE
McKesson | 8-K: Mckesson to Present at the 42nd Annual J.P. Morgan Healthcare Conference
McKesson | 8-K: Entry into a Material Definitive Agreement
McKesson | 8-K: McKESSON CORPORATION REPORTS FISCAL 2024 SECOND QUARTER RESULTS AND RAISES FULL YEAR GUIDANCE
McKesson | 8-K: Current report
McKesson | 8-K: Nancy Avila, Chief Information Officer and Chief Technology Officer, Resigns; Britt Vitalone, Executive Vice President and Chief Financial Officer, Extends Leadership
McKesson | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
McKesson | 8-K: McKESSON CORPORATION REPORTS FISCAL 2024 FIRST QUARTER RESULTS
McKesson | 8-K: Voting Results of McKesson Meeting
No Data
No Data